Teguh Aryanugraha, Djanggan Sargowo, Anna Fuji Rahimah, Cholid Tri Tjahjono
Cardiovascular diseases remain a major cause of morbidity and mortality worldwide. Cardiovascular diseases associated with metabolic disorders are collectively referred to as Cardiometabolic Diseases (CMDs). Oxidative stress and inflammation are key contributors to the development and progression of CMDs. Antioxidants and anti-inflammatory agents have garnered significant attention as potential therapeutic strategies for preventing and managing cardiovascular disorders. To better understand the complex interactions between oxidative stress, inflammation, and cardiovascular health, this review paper will focus on the mechanisms of action and potential advantages of antioxidants and anti-inflammatory drugs in reducing the risk factors associated with CVDs and enhancing cardiovascular health in general. © 2024, Brawijaya University. All rights reserved.
Brawijaya Cardiovascular Research Center, Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia; Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia
Research at a Glance
Register to unlockTopics & SDG Alignment
Register to unlockCollaboration
Register to unlockAuthor Profile (Selected)
Register to unlockReferences Overview
Register to unlockJournal & Source
Register to unlockMetadata & Integrity
Register to unlock